𝔖 Bobbio Scriptorium
✦   LIBER   ✦

2060 POSTER An open-label study of neoadjuvant capecitabine (C) and docetaxel (D) with/without trastuzumab (T) to determine the role of p53 mutations in clinical and pathological responses in patients with recently diagnosed breast cancer (BC)

✍ Scribed by P. Nancy; S. Truong; D. Tripathy; S. Glück; U. Dugan; L. Wu


Book ID
118625664
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
60 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES